BioCorRx Inc. (OTCMKTS:BICX) Short Interest Down 33.3% in September

by · The Markets Daily

BioCorRx Inc. (OTCMKTS:BICX – Get Free Report) was the recipient of a large decline in short interest in September. As of September 15th, there was short interest totalling 400 shares, a decline of 33.3% from the August 31st total of 600 shares. Based on an average daily volume of 900 shares, the short-interest ratio is currently 0.4 days.

BioCorRx Stock Performance

Shares of BICX stock remained flat at $0.32 during trading on Friday. The stock had a trading volume of 200 shares, compared to its average volume of 1,747. The company has a market cap of $3.13 million, a P/E ratio of -0.70 and a beta of 0.59. The business’s 50 day moving average is $0.39 and its two-hundred day moving average is $0.65. BioCorRx has a 52 week low of $0.28 and a 52 week high of $1.68.

BioCorRx (OTCMKTS:BICX – Get Free Report) last released its earnings results on Tuesday, August 13th. The company reported ($0.13) earnings per share (EPS) for the quarter.

BioCorRx Company Profile

(Get Free Report)

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.

See Also